SCHEMBL5776923

SCHEMBL5776923

NNC(=O)c1c(N)ccc2ncccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 2/20 0.54
LMNA P02545 2/20 0.54
HTT P42858 2/20 0.54
HSP90AA1 P07900 2/20 0.54
HSP90AB1 P08238 2/20 0.54
BLM P54132 1/20 0.54
HIF1A Q16665 1/20 0.54
KDM4E B2RXH2 1/20 0.47
P2RX7 Q99572 5/20 0.46
NSD2 O96028 1/20 0.43
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NCF1 P14598 1/20 0.41
ERN1 O75460 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40
IDO1 P14902 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986493 0.83 MEN1 (0.58) MEN1KMT2AMAPTLMNAHTT
SCHEMBL4074779 0.83 MAPT (0.58) MEN1KMT2AMAPTLMNAHTT
SCHEMBL11390283 0.82 MAPT (0.56) MEN1KMT2AMAPTLMNAHTT
SCHEMBL3984706 0.81 MEN1 (0.51) MEN1KMT2AMAPTLMNAHTT
Hydrazinecarboxamide SCHEMBL1464078 0.77 MEN1 (0.46) MEN1KMT2AMAPTLMNAHTT
SCHEMBL16572948 0.75 NSD2 (0.67) MEN1KMT2AMAPTLMNAHTT
Hydrazinecarboxamide SCHEMBL1464164 0.74 NCF1 (0.53) MEN1KMT2AMAPTLMNAHTT
SCHEMBL10775545 0.73 GAA (0.51) MEN1KMT2AMAPTHIF1AKDM4E
SCHEMBL7840621 0.72 HSP90AA1 (0.66) MEN1KMT2AMAPTLMNAHTT
SCHEMBL16717955 0.71 MAPT (0.59) MEN1KMT2AMAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003721-B1 BENZYLIDENE-1,3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS, PARTICULARLY OF RAF KINASES GLAXO GROUP LTD (GB) 2006-11-02 EP disclosed
US-6268391-B1 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases GLAXO WELLCOME INC. 2001-07-31 US disclosed
EP-1003721-A1 BENZYLIDENE-1,3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS, PARTICULARLY OF RAF KINASES GLAXO GROUP LIMITED (GB) 2000-05-31 EP disclosed
WO-1999010325-A1 BENZYLIDENE-1,3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS, PARTICULARLY OF RAF KINASES GLAXO GROUP LIMITED (GB) 1999-03-04 WO disclosed